These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8032876)

  • 1. Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brain.
    Mackay KB; McCulloch J
    Brain Res; 1994 Apr; 642(1-2):160-8. PubMed ID: 8032876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limbic brain structures are important sites of kappa-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study.
    Ableitner A; Herz A
    Brain Res; 1989 Jan; 478(2):326-36. PubMed ID: 2538203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of apomorphine upon local cerebral glucose utilization in conscious rats and in rats anesthetized with chloral hydrate.
    Grome JJ; McCulloch J
    J Neurochem; 1983 Feb; 40(2):569-76. PubMed ID: 6822839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat.
    Mackay KB; Kusumoto K; Graham DI; McCulloch J
    Brain Res; 1993 Nov; 629(1):10-8. PubMed ID: 8287264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor antagonists and local cerebral glucose utilization in the rat.
    Browne SE; McCulloch J
    Brain Res; 1994 Mar; 641(1):10-20. PubMed ID: 8019834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of effects of haloperidol on energy metabolism in the rat brain.
    McCulloch J; Savaki HE; Sokoloff L
    Brain Res; 1982 Jul; 243(1):81-90. PubMed ID: 7116160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation.
    Kelly PA; McCulloch J
    J Neurochem; 1982 Sep; 39(3):613-24. PubMed ID: 7097270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
    Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
    Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system.
    Cascella NG; Tarazi FI; Shirakawa O; Tamminga CA
    Psychopharmacology (Berl); 1994 Mar; 114(2):275-80. PubMed ID: 7838920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain sites involved in mu-opioid receptor-mediated actions: a 2-deoxyglucose study.
    Fabian I; Ableitner A
    Brain Res; 1995 Oct; 697(1-2):205-15. PubMed ID: 8593578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the rat.
    Lam AG; Monn JA; Schoepp DD; Lodge D; McCulloch J
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1083-91. PubMed ID: 10532632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.
    McCulloch J; Savaki HE; McCulloch MC; Jehle J; Sokoloff L
    Brain Res; 1982 Jul; 243(1):67-80. PubMed ID: 7116159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat.
    Mitchell EA; Pratt JA
    Brain Res; 1991 Jan; 538(2):289-94. PubMed ID: 1826459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex.
    Kurumaji A; McCulloch J
    Brain Res; 1990 Oct; 531(1-2):72-82. PubMed ID: 2289138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local changes in cerebral glucose utilization during ketamine anesthesia.
    Crosby G; Crane AM; Sokoloff L
    Anesthesiology; 1982 Jun; 56(6):437-43. PubMed ID: 7081728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of mazindol on local cerebral glucose utilization in rats.
    Kubota M; Namba H; Sunami K; Yamaura A; Makino H; Murano S; Nishikawa T; Oheda T; Saito Y; Yoshida S
    Neuropharmacology; 1987 Sep; 26(9):1403-8. PubMed ID: 3670561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
    Kurumaji A; McCulloch J
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.